This whitepaper examines how adaptive clinical trial designs in oncology can improve patient outcomes and treatment efficacy through real-time modifications, while also highlighting the regulatory and ethical challenges these designs pose within IRB frameworks. 

We interviewed 24 Medical Affairs leaders on the critical success factors for building a Best Practice Medical Affairs organization. This report shares what we learned.

Learn how speed and accuracy of clinical information is transforming healthcare delivery and how your brand can become part of these high-value clinical conversations at the point of decision-making. Download now.

Typical vaccine development timelines have averaged 10 years, but the time from the SARS-CoV-2 genetic sequence’s release to the submission of the first vaccine clinical trial data for regulatory review was a mere 314 days. In IQVIA Laboratories’ Vaccine eBook we focus on how contract research organizations (CROs) can best leverage strategic partnerships with sponsors to prepare for the next pandemic.

To improve market access, companies need to ensure that needed treatments reach the right patients at the right times and at affordable prices. To accomplish this optimal market access, companies must work closely with payer organizations, which typically control over which drugs are embraced by providers and their patients. This paper describes how companies can leverage real world data to support market access strategies such as: identifying the right payers for pilot programs, understanding payer preferences for specific drug classes or treatment pathways, and more. Download now.